Overview

The Effect of Xolair on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils

Status:
Unknown status
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
If you are allergic to ragweed, and not taking certain medications, you will be asked to have blood drawn. We will perform experiments on your blood cells.
Phase:
Phase 4
Details
Lead Sponsor:
Creighton University
Collaborator:
Novartis
Treatments:
Omalizumab